Oral Microbiota Taxa and Pri-miRNA Expression in Bipolar Disorder: A Case–Control Study

<b>Background/Objectives:</b> Emerging evidence suggests a role for oral microbiota in mood disorders, particularly bipolar disorder (BD), complementing established links between gut dysbiosis and psychiatric symptoms. This study investigates the composition of oral microbial taxa and the expression of inflammation-related pri-miRNAs (146a and 155) in individuals with BD, aiming to explore their potential as biomarkers in the oral-gut-brain axis. <b>Methods:</b> A matched case-control design was implemented, recruiting 25 BD patients and 46 controls matched by age and sex. Salivary samples were collected, and microbial profiling was conducted via real-time qPCR targeting major bacterial phyla and genera. Pri-miRNA 146a and 155 expression was evaluated through RT-qPCR using validated primers. Statistical comparisons between groups were performed using Fisher's exact test and non-parametric tests for continuous variables. <b>Results:</b> Microbial analysis revealed significant reductions (<i>p</i> < 0.01) in α-Proteobacteria, γ-Proteobacteria, and Actinobacteria in BD patients versus controls. A shift toward a higher Firmicutes/Bacteroidetes ratio was observed in the BD cohort, suggesting differences in the oral biotic status between the two groups. However, pri-miRNA 146a and 155 expression levels did not differ significantly between the groups and exhibited high inter-individual variability. <b>Conclusions:</b> The findings indicate that oral microbiota composition differs in BD patients, potentially influencing systemic homeostasis through interactions with gut microbial communities and SCFA pathways. These findings should be interpreted as preliminary and hypothesis-generating given the modest sample size. While pri-miRNAs 146a and 155 did not distinguish BD status, the observed microbial taxa alterations should be regarded as exploratory and hypothesis-generating. Larger, longitudinal studies are required to clarify their potential role in BD pathogenesis and risk assessment.

Authors

Institutions

Publication Details

Journal
Biomolecules
Published
2025-09-24
DOI
https://doi.org/10.3390/biom15101355
Citations
1
Primary Topic
Tryptophan and brain disorders
Type
article
Field-Weighted Citation Impact
0.58
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Oral Microbiota Taxa and Pri-miRNA Expression in Bipolar Disorder: A Case–Control Study

Alessandra Scano, Sara Fais, Ricardo Ramírez, Massimo Tusconi et al.
1 citations
Biomolecules
Tryptophan and brain disorders
0.58
article

Oral Microbiota Taxa and Pri-miRNA Expression in Bipolar Disorder: A Case–Control Study

Alessandra Scano, Sara Fais, Ricardo Ramírez, Massimo Tusconi, Goce Kalcev, Mauro Giovanni Carta, Diego Primavera, Cinzia Casu, Laura Atzori, Caterina Ferreli, Germano Orrù, Letizia Peddio
article en
1 citations

Abstract

<b>Background/Objectives:</b> Emerging evidence suggests a role for oral microbiota in mood disorders, particularly bipolar disorder (BD), complementing established links between gut dysbiosis and psychiatric symptoms. This study investigates the composition of oral microbial taxa and the expression of inflammation-related pri-miRNAs (146a and 155) in individuals with BD, aiming to explore their potential as biomarkers in the oral-gut-brain axis. <b>Methods:</b> A matched case-control design was implemented, recruiting 25 BD patients and 46 controls matched by age and sex. Salivary samples were collected, and microbial profiling was conducted via real-time qPCR targeting major bacterial phyla and genera. Pri-miRNA 146a and 155 expression was evaluated through RT-qPCR using validated primers. Statistical comparisons between groups were performed using Fisher's exact test and non-parametric tests for continuous variables. <b>Results:</b> Microbial analysis revealed significant reductions (<i>p</i> < 0.01) in α-Proteobacteria, γ-Proteobacteria, and Actinobacteria in BD patients versus controls. A shift toward a higher Firmicutes/Bacteroidetes ratio was observed in the BD cohort, suggesting differences in the oral biotic status between the two groups. However, pri-miRNA 146a and 155 expression levels did not differ significantly between the groups and exhibited high inter-individual variability. <b>Conclusions:</b> The findings indicate that oral microbiota composition differs in BD patients, potentially influencing systemic homeostasis through interactions with gut microbial communities and SCFA pathways. These findings should be interpreted as preliminary and hypothesis-generating given the modest sample size. While pri-miRNAs 146a and 155 did not distinguish BD status, the observed microbial taxa alterations should be regarded as exploratory and hypothesis-generating. Larger, longitudinal studies are required to clarify their potential role in BD pathogenesis and risk assessment.

BiomoleculesVol. 15(10)
University of Cagliari (IT), Popular University of Cesar (CO), Institute of Sciences of Food Production (IT), National Research Council (IT)
Openalex Percentile: Top 32%
Tryptophan and brain disorders
0.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.